Kyntra Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Kyntra Bio Inc.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
/ 
Others were interested in
Frequently asked questions
To buy Kyntra Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Kyntra Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Kyntra Bio Inc. is KYNB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Kyntra Bio Inc. has its primary listing on NASDAQ. You can trade Kyntra Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Kyntra Bio Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Kyntra Bio Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Kyntra Bio Inc..